These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1349757)

  • 1. Low dose neuroleptanxiolysis in anxiety states.
    Heinrich K; Lehmann E
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Mar; 16(2):135-43. PubMed ID: 1349757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Leading symptom of anxiety and tension and its concomitant somatic manifestations. A multicenter trial of fluspirilene versus bromazepam].
    Thilmann J
    Fortschr Med; 1983 Oct; 101(37):1676-8. PubMed ID: 6139327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental comparison of low doses of 1.5 mg fluspirilene and bromazepam in out-patients with psychovegetative disturbances.
    Hassel P
    Pharmacopsychiatry; 1985 Sep; 18(5):297-302. PubMed ID: 2864709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alternative therapy concept for the treatment of psychosomatic disorders. Controlled double-blind evaluation of fluspirilene versus bromazepam].
    Lehmann E; Hassel P; Thörner GW; Karrass W
    Fortschr Med; 1984 Oct; 102(40):1033-6. PubMed ID: 6149989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled comparison of two anxiolytic benzodiazepines, cloxazolam and bromazepam.
    Ansseau M; von Frenckell R
    Neuropsychobiology; 1990-1991; 24(1):25-9. PubMed ID: 1983433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative studies on the tranquilizer effect of fluspirilene and bromazepam].
    Thilmann J
    Med Welt; 1981 Dec; 32(51-52):1959-61. PubMed ID: 6120433
    [No Abstract]   [Full Text] [Related]  

  • 7. Test therapy in the treatment of generalized anxiety disorders with low dose fluspirilene.
    Wurthmann C; Klieser E; Lehmann E; Pester U
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Oct; 19(6):1049-60. PubMed ID: 8584682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromazepam in generalized anxiety. Randomized, multi-practice comparisons with both chlorprothixene and placebo.
    Kragh-Sørensen P; Holm P; Fynboe C; Schaumburg E; Andersen B; Bech P; Pichard J
    Psychopharmacology (Berl); 1990; 100(3):383-6. PubMed ID: 1969172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromazepam and diazepam in generalized anxiety: a placebo-controlled study with measurement of drug plasma concentrations.
    Fontaine R; Annable L; Chouinard G; Ogilvie RI
    J Clin Psychopharmacol; 1983 Apr; 3(2):80-7. PubMed ID: 6132936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromazepam ('Lexotanil') compared with placebo: a double-blind, crossover study.
    Rey A; Bovet J; Schneider PB
    Pharmatherapeutica; 1984; 4(1):13-20. PubMed ID: 6150491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparison of the anxiolytic activity of two benzodiazepines, metaclazepam and bromazepam, in anxiety neurosis.
    Bilone F; Roncari R
    Curr Med Res Opin; 1988; 11(1):45-7. PubMed ID: 2898321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind study of metaclazepam versus diazepam treatment of outpatients with anxiety syndrome.
    Laakmann G; Blaschke D; Hippius H; Schewe S
    Pharmacopsychiatry; 1989 May; 22(3):120-5. PubMed ID: 2568645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dose-effect relationship of 0.5, 1.0 and 1.5 mg fluspirilene on anxious patients.
    Lehmann E
    Neuropsychobiology; 1989; 21(4):197-204. PubMed ID: 2698453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled comparison of bromazepam, amitriptyline, and placebo in anxiety-depressive neurosis.
    Shammas E
    Dis Nerv Syst; 1977 Mar; 38(3):201-7. PubMed ID: 13969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of Cavain in patients suffering from anxiety.
    Lehmann E; Klieser E; Klimke A; Krach H; Spatz R
    Pharmacopsychiatry; 1989 Nov; 22(6):258-62. PubMed ID: 2575765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromazepam and lorazepam in generalized anxiety: a placebo-controlled study with measurement of drug plasma concentrations.
    Fontaine R; Mercier P; Beaudry P; Annable L; Chouinard G
    Acta Psychiatr Scand; 1986 Nov; 74(5):451-8. PubMed ID: 2880459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of bromazepam. Thirty cases (author's transl)].
    Sechter D; Petitjean F; Bitoun G
    Nouv Presse Med; 1982 May; 11(22):1744-6. PubMed ID: 6124949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromazepam, a new anxiolytic: a comparative study with diazepam in general practice. Royal College of General Practitioners Medicines Surveillance Organisation.
    Royal College of General Practitioners Medicines Surveillance Organisation
    J R Coll Gen Pract; 1984 Sep; 34(266):509-12. PubMed ID: 6147412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etizolam in the treatment of generalized anxiety disorder: a controlled clinical trial.
    Bertolino A; Mastucci E; Porro V; Corfiati L; Palermo M; Ecari U; Ceccarelli G
    J Int Med Res; 1989; 17(5):455-60. PubMed ID: 2572494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interaction of therapeutic effects and side effects in drug therapy of generalized anxiety disorders with low dosage fluspirilene].
    Wurthmann C; Klieser E; Lehmann E
    Fortschr Neurol Psychiatr; 1995 Feb; 63(2):72-7. PubMed ID: 7705742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.